Ahn-Gook Pharmaceutical Co Ltd banner
A

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540

Watchlist Manager
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Watchlist
Price: 7 940 KRW 1.66% Market Closed
Market Cap: ₩90.2B

Ahn-Gook Pharmaceutical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Ahn-Gook Pharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
A
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Research & Development
-₩18.9B
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Ahn-Gook Pharmaceutical Co Ltd
Glance View

Market Cap
90.2B KRW
Industry
Pharmaceuticals

AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.

Intrinsic Value
17 581.51 KRW
Undervaluation 55%
Intrinsic Value
Price
A

See Also

What is Ahn-Gook Pharmaceutical Co Ltd's Research & Development?
Research & Development
-18.9B KRW

Based on the financial report for Sep 30, 2025, Ahn-Gook Pharmaceutical Co Ltd's Research & Development amounts to -18.9B KRW.

What is Ahn-Gook Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-9%

Over the last year, the Research & Development growth was -54%. The average annual Research & Development growth rates for Ahn-Gook Pharmaceutical Co Ltd have been -14% over the past three years , -9% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett